Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Levi Buil"'
Autor:
Gerard Platenburg, Jingjing Zang, Erwin van Wijk, Margo Dona, Sanne Broekman, Jiayi Miao, Cathaline den Besten, Erik de Vrieze, Hee Lam Chan, Janne J. Turunen, Hanka Venselaar, Lars Vorthoren, Kalyan Dulla, Peter Adamson, Ralph Slijkerman, Stephan C.F. Neuhauss, Silvia Albert, Wouter Beumer, Theo A. Peters, Iris Schmidt, Hester van Diepen, Ronald J.E. Pennings, Hannie Kremer, Levi Buil, Iris Schulkens
Publikováno v:
Molecular Therapy, 29, 8, pp. 2441-2455
Mol Ther
Molecular Therapy, 29, 2441-2455
Mol Ther
Molecular Therapy, 29, 2441-2455
Mutations in USH2A are among the most common causes of syndromic and non-syndromic retinitis pigmentosa (RP). The two most recurrent mutations in USH2A, c.2299delG and c.2276G > T, both reside in exon 13. Skipping exon 13 from the USH2A transcript pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0009073ca7e61b8b3ea940e0d6aa4cb9
https://hdl.handle.net/1887/3627509
https://hdl.handle.net/1887/3627509
Autor:
Gerard Platenburg, Willeke M. C. van Roon-Mom, Herma Anthonijsz, Hyeongju Kim, Lodewijk J.A. Toonen, Nicholas S. Caron, Levi Buil, Michael R. Hayden, Zhana Karneva, Geert van der Horst, Frits van der Ham, Linda M. van der Graaf, Pontus Klein, Wouter Beumer, Ji-Joon Song
Publikováno v:
Experimental therapeutics – preclinical.
Background QRX-704 is a novel antisense oligonucleotide-based therapeutic approach, aiming to mitigate mutant Huntingtin (mHTT) toxicity, while maintaining physiological HTT function. Proteolytic cleavage of mHTT generates toxic N-terminal fragments
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5fa5570ed52547349af2c57b84d5030
https://doi.org/10.1136/jnnp-2018-ehdn.237
https://doi.org/10.1136/jnnp-2018-ehdn.237
Autor:
Selvi, Durmus, Jyoti, Naik, Levi, Buil, Els, Wagenaar, Olaf, van Tellingen, Alfred H, Schinkel
Publikováno v:
International journal of cancer. 135(7)
Organic anion-transporting polypeptides (OATPs) are important drug uptake transporters, mediating distribution of substrates to several pharmacokinetically relevant organs. Doxorubicin is a widely used anti-cancer drug extensively studied for its int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::de91d44f78107abe57bf8a9482340447
https://pubmed.ncbi.nlm.nih.gov/24554572
https://pubmed.ncbi.nlm.nih.gov/24554572
Publikováno v:
International journal of cancer. 133(5)
Palomid 529, a novel dual mTORC1/2 inhibitor has displayed interesting activities in experimental models and is a candidate for clinical evaluation. We have assessed the interaction of Palomid 529 with ATP-binding cassette (ABC) drug efflux transport
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9d911dcf6b7ac7bd54dc748a2cd9a072
https://pubmed.ncbi.nlm.nih.gov/23436212
https://pubmed.ncbi.nlm.nih.gov/23436212